Tumor lysis syndrome E88.3

  • E88.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2019 edition of ICD-10-CM E88.3 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of E88.3 - other international versions of ICD-10 E88.3 may differ.
Applicable To:
  • Tumor lysis syndrome (spontaneous)
  • Tumor lysis syndrome following antineoplastic drug chemotherapy
Use Additional:
  • code for adverse effect, if applicable, to identify drug (T45.1X5)

Codes: = Billable

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.